相关实验视频

Updated: Jun 29, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

工程化介素-6衍生的细胞因子招募人造受体综合体,并通过OSMR披露CNTF信号

Puyan Rafii¹, Patricia Rodrigues Cruz¹, Julia Ettich¹

¹Institute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

The Journal of biological chemistry

|April 3, 2024

概括

新的细胞因子仿真体,GIL-6和GIO-6,针对肥胖和胰岛素抵抗的特定受体综合体. GIL-6选择性地激活IL-6R:gp130:LIFR,提供了一种新的治疗方法.

科学领域:

* 细胞因子信号传递和受体复杂相互作用.
*开发新的治疗性蛋白质工程策略.

背景情况:

* 纤毛神经营养因子 (CNTF) 通过 CNTFR,gp130 和 LIFR 激活细胞.
*像Axokine这样的CNTF衍生物在治疗肥胖和胰岛素抵抗方面表现有前途,但由于抗体形成而面临临临床挑战.
*以前的仿真细胞因子IC7利用IL-6框架与CNTF的LIFR结合部位,激活IL-6R:gp130:LIFR复合体,并在小鼠模型中证明有效性.

研究的目的:

* 开发新型的CNTF独立的化学细胞因子,专门针对IL-6R:gp130:LIFR受体综合体.
* 设计具有增强选择性和代谢障碍治疗潜力的细胞因子.
* 为了确定现有的和新兴的仿制细胞因子的替代性受体相互作用.

主要方法:

* 通过将LIFR或OSM结合点转移到IL-6框架中来设计和构建GIL-6和GIO-6仿制细胞因子.
*研究受体激活通路,包括IL-6R:gp130:LIFR和IL-6R:gp130:OSMR复合体.
*重新评估IC7和CNTF相互作用以确定替代的高亲和受体,特别是哥斯塔丁M受体 (OSMR).

主要成果:

*GIL-6被设计为可以选择性地激活IL-6R:gp130:LIFR受体复合体.
*发现GIO-6通过IL-6R:gp130:LIFR和IL-6R:gp130:OSMR复合体发出信号.
*发现OSMR作为IC7和CNTF的替代高亲和受体,形成IL-6R:OSMR:gp130和CNTFR:OSMR:gp130复合体.
*GIL-6被确定为第一个真正选择性的IL-6R:gp130:LIFR细胞因子,GIO-6作为IC7.7的无CNTF替代品.

结论:

*新奇的仿制细胞因子GIL-6和GIO-6提供了不同的受体激活配置文件.
*GIL-6是一种高度选择性的治疗候选药物,向IL-6R:gp130:LIFR通路.
*将OSMR确定为替代受体扩大了对CNTF和IC7信号的理解,GIO-6提供了一个有价值的无CNTF选项.

关键词:

在CNTF中,CNTF是CNTF.在IL-6的研究中,IL-6被认为是IL-6的基因.一个LIF就是一个LIF.根据LIFR的规定.这是OSMR的OSMR.细胞因子细胞因子 gp13030 的使用情况.互乐金是一种介质蛋白.接收器接收器接收器接收器信号传输,信号传输.

更多相关视频

Identification of Functional Protein Regions Through Chimeric Protein Construction

Identification of Functional Protein Regions Through Chimeric Protein Construction

Published on: January 8, 2019

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...